Using antibodies against immune deficiency
Wednesday, September 26, 2012 - 10:30
in Health & Medicine
Early, intensive therapy with a biotechnologically produced medication can provide significantly faster pain relief for patients with rheumatic joint inflammation. Damage to joints can also be reduced when the medication is applied right at the beginning of the illness, according to new research.